Onconetix Insider Buying Soars: HRT Financial LP Accumulates 92,000 Shares Amid 97% Stock Plunge, Betting on a Rebound?
HRT Financial’s surge in Onconetix shares amid a steep price collapse signals insider confidence—and a potential turnaround—yet investors must weigh biotech risks and pending clinical data before buying.
3 minutes to read